Firefly Neuroscience, Inc.AIFFNASDAQ
Loading
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +43.48% | +178.95% | +258.33% | -84.29% | +1075.76% |
| Gross Profit Growth | -6356.52% | +178.95% | +258.33% | -59.86% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | -10.03% | +6.30% | +26.51% | +60.97% | +86.35% |
| Weighted Average Shares Diluted Growth | -10.03% | +6.30% | +26.51% | +60.97% | +90.62% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | -612.48% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | -645.84% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +104.76% | +44.05% | -87.11% | -75.12% | -100.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +431.63% | +74.21% | +228.39% | +351.31% | +133.61% |
| Book Value per Share Growth | +0.00% | +0.00% | +139.88% | +445.09% | +86.68% |
| Debt Growth | +0.00% | +0.00% | -100.00% | -100.00% | +0.00% |
| R&D Expense Growth | +123.98% | +1406.90% | +7.96% | +0.00% | -56.95% |
| SG&A Expenses Growth | +601.80% | +39.88% | +120.64% | +65.74% | +16.45% |